Halozyme Therapeutics, Inc. Share Price

Halozyme Therapeutics, Inc. Share Price

NASDAQ: HALO | Large Cap
$131.13
+$1.07 (0.82%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Halozyme Therapeutics, Inc. Stock Performance

Open
$130.76
Prev. Close
$130.06
Circuit Range
N/A
Day Range
$130.12 - $132.46
Year Range
$61.24 - $132.46
Volume
1,00,855
Average Traded
$131.10

Halozyme Therapeutics, Inc. Share Price Today

As of 30 October 2026, Halozyme Therapeutics, Inc.'s share price is $131.13. The stock opened at $130.76, compared to its previous close of $130.06. During today's trading session, Halozyme Therapeutics, Inc.'s share price traded between $130.12 and $132.46, with an average price of $131.29. Over the past 52 weeks, the stock has recorded a high of $132.46 and a low of $61.24. In terms of performance, Halozyme Therapeutics, Inc.'s share price has risen by 106.01% over the last six months and is up 101.24% on a year-on-year basis.

Halozyme Therapeutics, Inc. Share Price Chart

Line chart of the Halozyme Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 130.12 to 132.49, ending at 131.13.
$130.12$132.46
L
Show Current Price
H

Halozyme Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$15.71B
PE Ratio (TTM)
35.68
Dividend Yield
0.00%
EPS (TTM)
$3.64
Revenue (TTM)
$1.40T
Return On Equity (TTM)
288.13%
Profit Margin
22.69%
Debt to Equity
14.95
Quarterly Earnings Growth YoY
31.20%

Halozyme Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$354.26$451.77$376.71$481.00
Net Profit$175.23-$141.59$150.05$229.91
Net Profit Margin49.46%-31.34%39.83%47.80%
Income ChangeN/A-180.80%205.97%53.22%

Halozyme Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$660.12$829.25$1015.32$1396.61
Net Profit$202.13$281.59$444.09$316.89
Net Profit Margin30.62%33.96%43.74%22.69%
Income ChangeN/A39.31%57.71%-28.64%

About Halozyme Therapeutics, Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Halozyme Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$109.57
$131.06
+18.58%
Sep 2026
$107.94
$110.52
+3.37%
Aug 2026
$82.42
$106.92
+29.55%
Jul 2026
$78.42
$82.53
+5.53%
Jun 2026
$66.10
$78.21
+17.52%
May 2026
$63.41
$66.55
+4.56%
Apr 2026
$64.74
$63.65
-1.49%
Mar 2026
$69.05
$64.61
-7.09%
Feb 2026
$71.64
$69.55
-2.91%
Jan 2026
$67.73
$71.63
+6.47%
Dec 2025
$71.77
$67.28
-5.86%
Nov 2025
$65.45
$71.47
+9.68%

HALO Share Price FAQs